ChemicalBook
English   Japanese   Germany   Korea

11-(4-(2-hydroxyethyl)piperazin-1-yl)-2,3-dihydro-1H-benzo[4,5]imidazo[1,2-a]cyclopenta[d]pyridine-4-carbonitrile

, 384352-31-2, 结构式
CAS号:
384352-31-2
英文名:
11-(4-(2-hydroxyethyl)piperazin-1-yl)-2,3-dihydro-1H-benzo[4,5]imidazo[1,2-a]cyclopenta[d]pyridine-4-carbonitrile
英文别名:
11-[4-(2-hydroxyethyl)piperazin-1-yl]-2,3-dihydro-1H-cyclopenta[4,5]pyrido[1,2-a]benzimidazole-4-carbonitrile;1H-Cyclopenta[4,5]pyrido[1,2-a]benzimidazole-4-carbonitrile, 2,3-dihydro-11-[4-(2-hydroxyethyl)-1-piperazinyl]-;11-(4-(2-hydroxyethyl)piperazin-1-yl)-2,3-dihydro-1H-benzo[4,5]imidazo[1,2-a]cyclopenta[d]pyridine-4-carbonitrile
中文名:
中文别名:
CBNumber:
CB43867981
分子式:
C21H23N5O
分子量:
361.44
MOL File:
384352-31-2.mol

11-(4-(2-hydroxyethyl)piperazin-1-yl)-2,3-dihydro-1H-benzo[4,5]imidazo[1,2-a]cyclopenta[d]pyridine-4-carbonitrile化学性质

密度:
1.39±0.1 g/cm3(Predicted)
酸度系数(pKa):
14.96±0.10(Predicted)
安全信息

11-(4-(2-hydroxyethyl)piperazin-1-yl)-2,3-dihydro-1H-benzo[4,5]imidazo[1,2-a]cyclopenta[d]pyridine-4-carbonitrile性质、用途与生产工艺

11-(4-(2-hydroxyethyl)piperazin-1-yl)-2,3-dihydro-1H-benzo[4,5]imidazo[1,2-a]cyclopenta[d]pyridine-4-carbonitrile 上下游产品信息

上游原料

下游产品


11-(4-(2-hydroxyethyl)piperazin-1-yl)-2,3-dihydro-1H-benzo[4,5]imidazo[1,2-a]cyclopenta[d]pyridine-4-carbonitrile 生产厂家

供应商联系电话电子邮件国家产品数优势度
VITAS-BB 俄罗斯 6754 64
IFLAB-BB vasily.pinchuk@lifechemicals.com 加拿大 6706 69
Interbioscreen Ltd. screen@ibscreen.chg.ru 芬兰 6178 60
PHARMEKS Ltd. sales@pharmeks.com 芬兰 6350 50
 

384352-31-2, 11-(4-(2-hydroxyethyl)piperazin-1-yl)-2,3-dihydro-1H-benzo[4,5]imidazo[1,2-a]cyclopenta[d]pyridine-4-carbonitrile 相关搜索:

  • 384352-31-2
  • 1H-Cyclopenta[4,5]pyrido[1,2-a]benzimidazole-4-carbonitrile, 2,3-dihydro-11-[4-(2-hydroxyethyl)-1-piperazinyl]-
  • 11-[4-(2-hydroxyethyl)piperazin-1-yl]-2,3-dihydro-1H-cyclopenta[4,5]pyrido[1,2-a]benzimidazole-4-carbonitrile
  • 11-(4-(2-hydroxyethyl)piperazin-1-yl)-2,3-dihydro-1H-benzo[4,5]imidazo[1,2-a]cyclopenta[d]pyridine-4-carbonitrile
Copyright 2016 © ChemicalBook. All rights reserved